| Genetic and phenotypic attributes of splenic marginal zone lymphoma F Bonfiglio, A Bruscaggin, F Guidetti, L Terzi di Bergamo, M Faderl, ... Blood, The Journal of the American Society of Hematology 139 (5), 732-747, 2022 | 67 | 2022 |
| An atlas of cells in the human tonsil R Massoni-Badosa, S Aguilar-Fernández, JC Nieto, P Soler-Vila, ... Immunity 57 (2), 379-399. e18, 2024 | 34 | 2024 |
| Oral manifestation of Langerhans cell histiocytosis: a case report J Luz, D Zweifel, M Hüllner, M Bühler, M Rücker, B Stadlinger BMC Oral Health 18, 1-6, 2018 | 29 | 2018 |
| The combined expression of the stromal markers fibronectin and SPARC improves the prediction of survival in diffuse large B-cell lymphoma S Brandt, C Montagna, A Georgis, PJ Schüffler, MM Bühler, B Seifert, ... Experimental hematology & oncology 2, 1-7, 2013 | 21 | 2013 |
| Enhanced engraftment of human myelofibrosis stem and progenitor cells in MISTRG mice V Lysenko, N Wildner-Verhey van Wijk, K Zimmermann, MC Weller, ... Blood advances 4 (11), 2477-2488, 2020 | 17 | 2020 |
| Towards precision medicine in lymphoid malignancies MM Bühler, JI Martin‐Subero, Q Pan‐Hammarström, E Campo, ... Journal of Internal Medicine 292 (2), 221-242, 2022 | 16 | 2022 |
| Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression A Valera, S Epistolio, L Colomo, A Riva, O Balagué, I Dlouhy, A Tzankov, ... Modern Pathology 29 (8), 844-853, 2016 | 10 | 2016 |
| Molecular and immunophenotypic characterization of SMARCB1 (INI1)-deficient intrathoracic Neoplasms M Haberecker, MM Bühler, AP Mendieta, R Guggenberger, F Arnold, ... Modern Pathology 35 (12), 1860-1869, 2022 | 8 | 2022 |
| SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues MM Bühler, J Lu, S Scheinost, F Nadeu, D Roos-Weil, M Hensel, ... Leukemia research 107, 106608, 2021 | 8 | 2021 |
| BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases A Carbo-Meix, F Guijarro, L Wang, M Grau, R Royo, G Frigola, ... Haematologica 109 (2), 493, 2024 | 5 | 2024 |
| MYC and TP53 Alterations but Not MAPK Pathway Mutations Are Common Oncogenic Mechanisms in Follicular Dendritic Cell Sarcomas G Frigola, M Bühler, M Marginet, A Enjuanes, F Nadeu, N Papaleo, ... Archives of Pathology & Laboratory Medicine 147 (8), 896-906, 2023 | 5 | 2023 |
| A rare case of classical Hodgkin lymphoma diagnosed 10 years after liver transplant L Zhang, R Pereira Mestre, F Bihl, M Bühler, B Vannata, A Stathis Case reports in oncology 10 (3), 923-927, 2018 | 5 | 2018 |
| Addressing Modern Diagnostic Pathology for Patient-Derived Soft Tissue Sarcosphere Models in the Era of Functional Precision Oncology Y Chen, M Herzog, A Pliego-Mendieta, MM Bühler, KJ Harnisch, ... Laboratory Investigation 103 (4), 100039, 2023 | 3 | 2023 |
| Polymorphisms of SOCS-1 are associated with a rapid HIV progression rate M Hersberger, E Schlaepfer, M Buehler, PY Bochud, P Vernazza, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 84 (2), 189-195, 2020 | 3 | 2020 |
| Conservative surgical treatment with fertility preservation in a young adult with NTRK rearranged spindle cell neoplasm of the uterine cervix MM Bühler, H Honcharova-Biletska, C Pauli, D Chronas, K Bolten Gynecologic Oncology Reports 48, 101233, 2023 | 2 | 2023 |
| Pathology of primary splenic B-cell lymphomas: a review M Bühler, E Matutes, M Rozman, E Campo Diagnostic Histopathology 26 (9), 398-406, 2020 | 2 | 2020 |
| Suppressors of cytokine signalling (SOCS) in human immunodeficiency virus (HIV) pathogenesis MM Bühler University of Zurich, 2015 | 1 | 2015 |
| Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma E Özoğul, A Montaner, M Pol, G Frigola, O Balagué, C Syrykh, ... Blood Cancer Journal 14 (1), 166, 2024 | | 2024 |
| Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells L Volta, R Myburgh, C Pellegrino, C Koch, M Maurer, F Manfredi, ... Leukemia, 1-16, 2024 | | 2024 |
| Three years follow-up of Venetoclax in advanced-stage, relapsed or refractory AL amyloidosis with cardiac involvement and t (11; 14) with BCL2 expression MJ Rieger, T Pabst, B Jeker, P Paul, F Bergamini, MM Bühler, ... Annals of hematology, 1-8, 2024 | | 2024 |
